menu
    • menu

    Company profile for Pieris Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pieris is a clinical-stage biotechnology company that discovers and develops Anticalin protein-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes inhalable Anticalin proteins to treat respiratory diseases and immuno-oncology multi-specifics tailored for the tumor microenvironment. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the...
    Pieris is a clinical-stage biotechnology company that discovers and develops Anticalin protein-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes inhalable Anticalin proteins to treat respiratory diseases and immuno-oncology multi-specifics tailored for the tumor microenvironment. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pieris PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    255 State Street, 9th floor Boston, MA 02109
    Telephone
    Telephone
    +1 (857) 246-8998
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pieris.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pieris-pharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Palvella Closes Merger With Pieris, Raises $78.9M
    Palvella Closes Merger With Pieris, Raises $78.9M

    13 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/13/2997010/0/en/Palvella-Therapeutics-Announces-Closing-of-Merger-with-Pieris-Pharmaceuticals-and-Concurrent-Private-Placement-of-78-9-Million.html

    GLOBENEWSWIRE
    13 Dec 2024
    Share Share
    Pieris Announces Strategy to Maximize Partnered Milestone and Royalty Potential
    Pieris Announces Strategy to Maximize Partnered Milestone and Royalty Potential

    27 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/847235/pieris-pharmaceuticals-announces-strategy-to-maximize-partnered-milestone-and-royalty-potential

    ACCESSWIRE
    27 Mar 2024
    Share Share
    Pieris lays off 70% of staff after AstraZeneca axes collab
    Pieris lays off 70% of staff after AstraZeneca axes collab

    19 Jul 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astrazeneca-bails-pieris-asthma-asset-thrusting-biotech-restructuring-70-layoffs

    Max Bayer FIERCE BIOTECH
    19 Jul 2023
    Share Share
    Pieris completes safety review of 10mg dose in asthma drug Phase IIa trial
    Pieris completes safety review of 10mg dose in asthma drug Phase IIa trial

    05 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/pieris-review-asthma-drug/

    CLINICAL TRIALS ARENA
    05 May 2023
    Share Share
    Pieris puts phase 2 cancer drug out on chopping block
    Pieris puts phase 2 cancer drug out on chopping block

    05 Aug 2022

    // Gabrielle Masson FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/too-many-cooks-kitchen-pieris-culls-phase-2-cancer-drug-focus-astrazeneca-asthma-collab

    Gabrielle Masson FIERCEBIOTECH
    05 Aug 2022
    Share Share
    Pieris doses first subject in Phase II gastric cancer drug trial
    Pieris doses first subject in Phase II gastric cancer drug trial

    17 Jan 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/pieris-dosing-gastric-cancer-trial/

    CLINICALTRIALSARENA
    17 Jan 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search